logo
Share SHARE
FONT-SIZE Plus   Neg

Vodafone Group's Vodafone Global Enterprise Acquires Bluefish Communications

British telecom giant Vodafone Group plc (VOD,VOD.L) Thursday said its Vodafone Global Enterprise, which manages the communications needs of its largest multinational customers, is acquiring European IT and communications consultancy, Bluefish Communications Ltd.

The company stated that Bluefish will form the nucleus of a new Unified Communications and Collaboration practice within Vodafone Global Enterprise, which will focus on advising multinational companies on how to get the most from their mobile, fixed line and IT services, as well as offering guidance on the adoption of cloud services.

Unified Communications seeks to make fixed and mobile communications more efficient, optimise and reduce costs, and enable better collaboration between employees, business partners and clients. The acquisition will expand Bluefish's geographical reach as it becomes part of Vodafone Global Enterprise's global network.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Snack and beverage giant Pepsico Inc. reported Thursday significantly higher profit in its third quarter, reflecting the absence of last year's hefty Venezuelan impairment charges, despite weak revenues. Core earnings and revenues beat market estimates. Further, the company lifted its fiscal 2016 forecast on its performance and outlook for the fourth quarter. Almost 71 percent of Americans say they don't save enough for their retirement, while around 54 percent believe they will never pay off their debt fully, according to a new national survey. The latest survey, commissioned by Experian together with Get Rich Slowly and other top U.S. personal finance... The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provides a sea of opportunity and huge upside prospects.
comments powered by Disqus
Follow RTT